The standard care of glioblastomas (GBM) confers limited survival benefit for patients due to the rapid tumor recurrence. Targeting tumor-associated macrophages/microglia via colony-stimulating factor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results